Utah
Cancer clinical trials in Utah
230 cancer studies are recruiting participants at sites in 15 cities across Utah as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Utah city with a recruiting study
By research area: Breast Cancer (67), Lymphoma (65), Lung Cancer (42), Prostate Cancer (24), Melanoma (18), Pancreatic Cancer (14).
Salt Lake City (174), West Valley City (44), Murray (14), Ogden (7), Farmington (6), St. George (5), Cedar City (4), South Jordan (3), American Fork (2), Logan (2), Provo (2), Riverton (2), Draper (1), Salt Lake City, UT (1), Sandy City (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Utah
Basic details from each study's public record (the 12 most recently updated of 230). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Recruiting in
- Salt Lake City · West Valley City
- Registry record
- NCT07488676 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Utah on ClinicalTrials.gov.
Lung cancer: recently updated in Utah
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Recruiting in
- West Valley City
- Registry record
- NCT07277413 · updated
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Recruiting in
- Salt Lake City
- Registry record
- NCT07063745 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Recruiting in
- Salt Lake City
- Registry record
- NCT07659782 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Utah on ClinicalTrials.gov.
Prostate cancer: recently updated in Utah
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Novartis Pharmaceuticals
- Recruiting in
- Salt Lake City
- Registry record
- NCT07190300 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Utah on ClinicalTrials.gov.
Lymphoma: recently updated in Utah
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- No phase
- Ages 1 to 25
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Salt Lake City
- Registry record
- NCT05621291 · updated
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eastern Cooperative Oncology Group
- Recruiting in
- Salt Lake City
- Registry record
- NCT06724237 · updated
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Recruiting in
- Salt Lake City
- Registry record
- NCT07221500 · updated
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Phase 1
- Ages 0 to 18
- All sexes
- Sponsor
- Autolus Limited
- Recruiting in
- Salt Lake City
- Registry record
- NCT06173518 · updated
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Murray · St. George
- Registry record
- NCT06890884 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Utah on ClinicalTrials.gov.
Pancreatic cancer: recently updated in Utah
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Recruiting in
- Salt Lake City
- Registry record
- NCT07522073 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Recruiting in
- West Valley City
- Registry record
- NCT07644559 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Utah on ClinicalTrials.gov.
Ask about studies in Utah
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections